Margaret Hamburg, M.D.
Co-president, InterAcademy Partnership
Margaret A. Hamburg, MD, Joins NTI as Interim Vice President for NTI | bio
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
NTI, Concordia AI Launch International Working Group to Improve Biological Capability Evaluations
NTI | bio and Concordia AI, with technical input from SecureBio, have launched the AIxBio Technical Working Group on Evaluation Practice. Convened through the AIxBio Global Forum, the Working Group will bring together experts from organizations in China, the European Union, the United Kingdom, and the United States that develop or conduct biological capability evaluations of AI systems.
NTI Engages Senior Congressional Staff with New Congressional Leadership Project (CLP)
A bipartisan, bicameral group of 17 senior congressional staff completed the inaugural edition of NTI’s new Congressional Leadership Project.
Africa’s Health Security Capacity Has Improved, but No Country is Adequately Prepared and Biosecurity and Biosafety Remain Critically Low
New Africa Health Security Index reveals how rising threats and health emergencies, including Central Africa’s current Ebola outbreak, could erode progress
